|
Volumn 25, Issue 2, 2003, Pages
|
Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus.
a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMNIOCENTESIS;
ARTICLE;
CANADA;
CLINICAL TRIAL;
DISEASE TRANSMISSION;
FEMALE;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MEDLINE;
META ANALYSIS;
METHODOLOGY;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY COMPLICATION;
PRENATAL DIAGNOSIS;
RISK FACTOR;
VIROLOGY;
AMNIOCENTESIS;
CANADA;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HEPATITIS B;
HEPATITIS C;
HIV INFECTIONS;
HUMANS;
MEDLINE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PRENATAL DIAGNOSIS;
RISK FACTORS;
MLCS;
MLOWN;
|
EID: 0037313784
PISSN: 17012163
EISSN: None
Source Type: Journal
DOI: 10.1016/s1701-2163(16)30211-0 Document Type: Article |
Times cited : (35)
|
References (0)
|